23
Participants
Start Date
March 31, 2008
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2011
forodesine HCl
2 x 100mg capsules daily
Cabrini Hospital, Malvern
Frankston Hospital, Frankston
Royal Brisbane and Women's Hospital, Brisbane
Weill Cornell Medical College, New York
Roswell Park Cancer Institute, Buffalo
Center for Cancer & Blood Disorders, PC, Bethesda
Indiana University Cancer Pavillion, Indianapolis
Washington University School of Medicine, St Louis
UCLA Medical Center, Los Angeles
Tower Cancer Research Foundation, Beverly Hills
Oregon Health & Science University, Portland
Lead Sponsor
BioCryst Pharmaceuticals
INDUSTRY